{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:25:32Z","timestamp":1740108332364,"version":"3.37.3"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T00:00:00Z","timestamp":1546992000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s00228-019-02626-z","type":"journal-article","created":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T17:27:48Z","timestamp":1547054868000},"page":"733-735","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Different effects of glucocorticoids on darunavir plasma concentrations"],"prefix":"10.1007","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1512-6530","authenticated-orcid":false,"given":"Dario","family":"Cattaneo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Cheli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Fusi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"Clementi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Gervasoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,9]]},"reference":[{"key":"2626_CR1","doi-asserted-by":"publisher","first-page":"653","DOI":"10.2133\/dmpk.DMPK-12-NT-018","volume":"27","author":"T Matsunaga","year":"2012","unstructured":"Matsunaga T, Maruyama M, Matsubara T, Nagata K, Yamazoe Y, Ohmori S (2012) Mechanisms of CYP3A induction by glucocorticoids in human fetal liver cells. Drug Metab Pharmacokinet. 27:653\u2013657","journal-title":"Drug Metab Pharmacokinet."},{"key":"2626_CR2","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1124\/dmd.31.5.620","volume":"31","author":"H Wang","year":"2003","unstructured":"Wang H, Faucette SR, Gilbert D, Jolley SL, Sueyoshi T, Negishi M et al (2003) Glucocorticoid receptor enhancement of pregnane X receptor-mediated CYP2B6 regulation in primary human hepatocytes. Drug Metab Dispos 31:620\u2013630","journal-title":"Drug Metab Dispos"},{"key":"2626_CR3","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1124\/dmd.30.9.1029","volume":"30","author":"W El-Sankary","year":"2002","unstructured":"El-Sankary W, Bombail V, Gibson GG, Plant N (2002) Glucocorticoid-mediated induction of CYP3A4 is decreased by disruption of a protein: DNA interaction distinct from the pregnane X receptor response element. Drug Metab Dispos 30:1029\u20131034","journal-title":"Drug Metab Dispos"},{"key":"2626_CR4","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1517\/17425255.2014.878703","volume":"10","author":"P Matoulkov\u00e1","year":"2014","unstructured":"Matoulkov\u00e1 P, P\u00e1vek P, Mal\u00fd J, Vl\u010dek J (2014) Cytochrome P450 enzyme regulation by glucocorticoids and consequences in terms of drug interaction. Expert Opin Drug Metab Toxicol 10:425\u2013435","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2626_CR5","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1093\/jac\/dku131","volume":"69","author":"M Arab-Alameddine","year":"2014","unstructured":"Arab-Alameddine M, Lubomirov R, Fayet-Mello A, Aouri M, Rotger M, Buclin T et al (2014) Population pharmacokinetic modelling and evaluation of different dosage regimens for darunavir and ritonavir in HIV-infected individuals. J Antimicrob Chemother 69:2489\u20132498","journal-title":"J Antimicrob Chemother"},{"key":"2626_CR6","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1046\/j.1523-1755.2002.00531.x","volume":"62","author":"D Cattaneo","year":"2002","unstructured":"Cattaneo D, Perico N, Gaspari F, Gotti E, Remuzzi G (2002) Glucocorticoids interfere with mycophenolate mofetil bioavailability in kidney transplantation. Kidney Int 62:1060\u20131067","journal-title":"Kidney Int"},{"key":"2626_CR7","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/j.1432-2277.2003.tb00230.x","volume":"16","author":"EM Duijnhoven van","year":"2003","unstructured":"van Duijnhoven EM, Boots JM, Christiaans MH, Stolk LM, Undre NA, van Hooff JP (2003) Increase in tacrolimus trough levels after steroid withdrawal. Transpl Int 16:721\u2013725","journal-title":"Transpl Int"},{"key":"2626_CR8","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2133\/dmpk.DMPK-13-RG-060","volume":"29","author":"K Hosohata","year":"2014","unstructured":"Hosohata K, Uesugi M, Hashi S, Hosokawa M, Inui K, Matsubara K et al (2014) Association between CYP3A5 genotypes in graft liver and increase in tacrolimus biotransformation from steroid treatment in living-donor liver transplant patients. Drug Metab Pharmacokinet 29:83\u201389","journal-title":"Drug Metab Pharmacokinet"},{"key":"2626_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2217\/pgs.12.187","volume":"14","author":"L Elens","year":"2013","unstructured":"Elens L, van Gelder T, Hesselink DA, Haufroid V, van Schaik RH (2013) CYP3A4*22: promising newly identified CYP3A4 variant allele for personalizing pharmacotherapy. Pharmacogenomics 14:47\u201362","journal-title":"Pharmacogenomics"},{"key":"2626_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fgene.2013.00012","volume":"4","author":"K Klein","year":"2013","unstructured":"Klein K, Zanger UM (2013) Pharmacogenomics of cytochrome P450 3A4: recent Progress toward the \"missing heritability\" problem. Front Genet 4:12\u201318","journal-title":"Front Genet"},{"key":"2626_CR11","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1038\/clpt.2011.336","volume":"91","author":"K Klein","year":"2012","unstructured":"Klein K, Thomas M, Winter S, Nussler AK, Niemi M, Schwab M et al (2012) PPARA: a novel genetic determinant of CYP3A4 in vitro and in vivo. Clin Pharmacol Ther 91:1044\u20131052","journal-title":"Clin Pharmacol Ther"},{"key":"2626_CR12","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s00228-014-1656-3","volume":"70","author":"I Lunde","year":"2014","unstructured":"Lunde I, Bremer S, Midtvedt K, Mohebi B, Dahl M, Bergan S et al (2014) The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipients. Eur J Clin Pharmacol 70:685\u2013693","journal-title":"Eur J Clin Pharmacol"},{"key":"2626_CR13","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1086\/592304","volume":"47","author":"M Siccardi","year":"2008","unstructured":"Siccardi M, D\u2019Avolio A, Baietto L, Gibbons S, Sciandra M, Colucci D et al (2008) Association of a single-nucleotide polymorphism in the pregnane X receptor (PXR 63396C-->T) with reduced concentrations of unboosted atazanavir. Clin Infect Dis 47:1222\u20131225","journal-title":"Clin Infect Dis"},{"key":"2626_CR14","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1093\/jac\/dkw032","volume":"71","author":"C Marzolini","year":"2016","unstructured":"Marzolini C, Gibbons S, Khoo S, Back D (2016) Cobicistat versus ritonavir boosting and differences in the drug-drug interaction profiles with co-medications. J Antimicrob Chemother 71:1755\u20131758","journal-title":"J Antimicrob Chemother"},{"key":"2626_CR15","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1111\/jphp.12820","volume":"69","author":"MA Hossain","year":"2017","unstructured":"Hossain MA, Tran T, Chen T, Mikus G, Greenblatt DJ (2017) Inhibition of human cytochromes P450 in vitro by ritonavir and cobicistat. J Pharm Pharmacol 69:1786\u20131793","journal-title":"J Pharm Pharmacol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-019-02626-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-019-02626-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-019-02626-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T19:10:02Z","timestamp":1578510602000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-019-02626-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,9]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["2626"],"URL":"https:\/\/doi.org\/10.1007\/s00228-019-02626-z","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"type":"print","value":"0031-6970"},{"type":"electronic","value":"1432-1041"}],"subject":[],"published":{"date-parts":[[2019,1,9]]},"assertion":[{"value":"15 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest. The work was not funded or supported.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Both patients provided signed informed consent for pharmacogenetic analyses.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent of the patients"}}]}}